Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protocol for mitomycin C use in glaucoma surgery.

J A Maquet1, E Dios, J Aragón

  • 1Department of Ophthalmology, University Hospital, University of Valladolid, Valladolid, Spain. maquet@teleline.es

Acta Ophthalmologica Scandinavica
|April 1, 2005
PubMed
Summary

This study found that different concentrations of mitomycin C (MMC) used in glaucoma surgery did not significantly impact intraocular pressure (IOP) control or complications. The protocol effectively lowered IOP across all tested MMC concentrations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced glaucoma. Clinical practice guideline.

Archivos de la Sociedad Espanola de Oftalmologia·2022
Same author

Guidelines for treatment of chronic primary angle-closure glaucoma.

Archivos de la Sociedad Espanola de Oftalmologia·2014
Same author

Radiological risk and radiation of the percutaneous nephrolithotomy patient.

Actas urologicas espanolas·2013
Same author

[Conjunctival myeloid sarcoma in acute myeloblastic leukemia-M1].

Archivos de la Sociedad Espanola de Oftalmologia·2012
Same author

Comparative study of topical anaesthesia with lidocaine 2% vs levobupivacaine 0.75% in cataract surgery.

British journal of anaesthesia·2009
Same author

[Decompression retinopathy with maculopathy after trabeculectomy with mitomycin C].

Archivos de la Sociedad Espanola de Oftalmologia·2008

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Pharmacology

Background:

  • Trabeculectomy and combined phacoemulsification-trabeculectomy are standard glaucoma surgeries.
  • Mitomycin C (MMC) is an antifibrotic agent used to enhance surgical success.
  • Optimizing MMC concentration is crucial for balancing efficacy and safety.

Purpose of the Study:

  • To evaluate the efficacy and safety of a specific protocol for mitomycin C (MMC) application in trabeculectomy and combined surgeries.
  • To determine if varying MMC concentrations (0.1, 0.2, 0.4 mg/ml) affect surgical outcomes.
  • To assess the impact of MMC on intraocular pressure (IOP) control and postoperative complications.

Main Methods:

  • A prospective study involving 143 eyes of 124 patients undergoing glaucoma surgery.

Related Experiment Videos

  • Patients were divided into four groups: no MMC, 0.1 mg/ml MMC, 0.2 mg/ml MMC, and 0.4 mg/ml MMC, with a 2-minute application time.
  • Intraocular pressure (IOP) and complications were evaluated at 1-year follow-up. Successful IOP control was defined as <21 mmHg, or <16 mmHg for advanced glaucoma.

    • Main Results:

    • Mean preoperative IOP of 24.60 mmHg decreased significantly to 13.47 mmHg at 12 months postoperatively (p < 0.00001).
    • Overall IOP control was achieved in 79.02% of eyes.
    • No statistically significant differences in final mean IOP or postoperative complications were observed among the groups using MMC (p > 0.120).

    Conclusions:

    • The described protocol for mitomycin C (MMC) use in glaucoma surgery is effective in lowering IOP.
    • Different concentrations of MMC (0.1, 0.2, 0.4 mg/ml) did not yield significant differences in IOP control or complication rates.
    • The study suggests that a range of MMC concentrations can be effectively selected based on clinical presentation without compromising outcomes.